Global CRO scale Fountain Medical Development operates a global CRO footprint with offices in Asia, the US, and Europe and serves seven of the top ten pharma companies, indicating strong capacity to support multinational clinical programs and complex regulatory requirements.

Multi regional demand Experience with China, US, Japan, and Europe suggests readiness to handle region-specific regulatory pathways, enabling sales conversations with sponsors seeking global registration trials and market entry support.

Regulatory readiness Active involvement in regulatory reform in China and extensive ICH GCP compliant services positions FMD as a partner for sponsors aiming to leverage evolving Chinese pathways and accelerated timelines.

Clinical depth Dozens of registration trials supporting marketing authorization indicate proven track record in late-phase studies, which can reassure sponsors prioritizing robust regulatory submissions and outcomes.

Scalable talent A wide, linguistically diverse team of 1,700+ professionals across 20 offices enables flexible resourcing models for programs of varying complexity and scale, including startups and established players.